Clinical Trial Update: Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of a Livalo fixed-dose combination containing pitavastatin in healthy subjects; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• LIVALO (pitavastatin calcium)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Hyperlipidemia, Hypertension | Phase 1 | Status: COMPLETED